Serotonin transporter occupancy by the SSRI citalopram predicts default-mode network connectivity

[1]  G. Fink,et al.  Resting state default mode network connectivity in children and adolescents with ADHD after acute tryptophan depletion , 2016, Acta psychiatrica Scandinavica.

[2]  U. Habel,et al.  Serotonergic modulation of resting state default mode network connectivity in healthy women , 2016, Amino Acids.

[3]  A. Hofman,et al.  Use of selective serotonin re-uptake inhibitors and the heart rate corrected QT interval in a real-life setting: the population-based Rotterdam Study. , 2015, British journal of clinical pharmacology.

[4]  Maarten Mennes,et al.  Evaluation of ICA-AROMA and alternative strategies for motion artifact removal in resting state fMRI , 2015, NeuroImage.

[5]  Serge A. R. B. Rombouts,et al.  Single-dose serotonergic stimulation shows widespread effects on functional brain connectivity , 2014, NeuroImage.

[6]  Stephen M. Smith,et al.  Permutation inference for the general linear model , 2014, NeuroImage.

[7]  Guillén Fernández,et al.  Short-term antidepressant administration reduces default mode and task-positive network connectivity in healthy individuals during rest , 2014, NeuroImage.

[8]  Pia Baldinger,et al.  Regional differences in SERT occupancy after acute and prolonged SSRI intake investigated by brain PET , 2014, NeuroImage.

[9]  Elia Formisano,et al.  Escitalopram Decreases Cross-Regional Functional Connectivity within the Default-Mode Network , 2013, PloS one.

[10]  G. Kranz,et al.  Differential modulation of the default mode network via serotonin-1A receptors , 2012, Proceedings of the National Academy of Sciences.

[11]  Sophie Guionnet,et al.  Brain effects of antidepressants in major depression: a meta-analysis of emotional processing studies. , 2011, Journal of affective disorders.

[12]  Yasumasa Okamoto,et al.  Modulation of default-mode network activity by acute tryptophan depletion is associated with mood change: A resting state functional magnetic resonance imaging study , 2011, Neuroscience Research.

[13]  M. Mintun,et al.  Resting-state functional MRI in depression unmasks increased connectivity between networks via the dorsal nexus , 2010, Proceedings of the National Academy of Sciences.

[14]  Stephen M Smith,et al.  Correspondence of the brain's functional architecture during activation and rest , 2009, Proceedings of the National Academy of Sciences.

[15]  N. Filippini,et al.  Group comparison of resting-state FMRI data using multi-subject ICA and dual regression , 2009, NeuroImage.

[16]  A. Schene,et al.  Evidence Why Paroxetine Dose Escalation is Not Effective in Major Depressive Disorder: A Randomized Controlled Trial With Assessment of Serotonin Transporter Occupancy , 2009, Neuropsychopharmacology.

[17]  Stephen M. Smith,et al.  Threshold-free cluster enhancement: Addressing problems of smoothing, threshold dependence and localisation in cluster inference , 2009, NeuroImage.

[18]  D. Schacter,et al.  The Brain's Default Network , 2008, Annals of the New York Academy of Sciences.

[19]  G. Glover,et al.  Resting-State Functional Connectivity in Major Depression: Abnormally Increased Contributions from Subgenual Cingulate Cortex and Thalamus , 2007, Biological Psychiatry.

[20]  J. Booij,et al.  Quantification of striatal dopamine transporters with 123I-FP-CIT SPECT is influenced by the selective serotonin reuptake inhibitor paroxetine: a double-blind, placebo-controlled, crossover study in healthy control subjects. , 2007, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[21]  R. Lanzenberger,et al.  In vivo imaging of serotonin transporter occupancy by means of SPECT and [123I]ADAM in healthy subjects administered different doses of escitalopram or citalopram , 2006, Psychopharmacology.

[22]  Mark W. Woolrich,et al.  Advances in functional and structural MR image analysis and implementation as FSL , 2004, NeuroImage.

[23]  Sylvain Houle,et al.  Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [11C]DASB positron emission tomography study. , 2004, The American journal of psychiatry.

[24]  A. Schene,et al.  Evidence why paroxetine dose escalation is not effective in major depressive disorder: a randomized controlled trial with assessment of serotonin transporter occupancy. , 2009, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.